Venture Partners

CID Equity Partners, CID Equity Partners, founded in 1981, is a leading provider of private equity and debt financing to high growth companies throughout the Mid-America region. From offices in Indianapolis, Indiana, Chicago, Illinois, and Columbus, Ohio, the firm is actively managing seed, venture and mezzanine capital funds, which together total nearly $400 million. Industries of interest include Information Technology, Life Sciences, Business Services and Manufacturing.

Visit their website

Early Stage Partners LP is an early stage venture capital fund based in Cleveland, Ohio. Early Stage Partners was developed to fill the gap that exists in funding for early stage companies with small- to medium-size capital requirements, particularly in Northeast Ohio. The company invests primarily in promising opportunities in the life sciences technology areas including software, supply chain management and advanced manufacturing, and polymers and advanced materials.

Visit their website

Investor Growth Capital ("IGC") is the wholly owned venture capital arm of Investor AB.  Investor, publicly traded on the Stockholm exchange, is the largest listed industrial holding company in the Nordic region and was founded in 1916 to continue the Wallenberg family´s tradition of financing and building best-in-class companies. Since its formation in the mid-1990s, IGC has continued to invest in high-quality, growth-oriented companies, primarily in the information technology and healthcare industries, in North America, Northern Europe and Asia. IGC´s 25 investment professionals manage a portfolio whose value exceeds USD $800 million from offices located in New York, Menlo Park, Beijing, Hong Kong, Tokyo, Stockholm and Amsterdam. IGC pursues investments where they can partner with talented and motivated management teams that are operating in markets and offering products or services likely to produce strong and sustainable growth.

MB Venture Partners is a Memphis, Tennessee venture capital firm that provides venture capital and strategic direction to life sciences companies. The Firm invests in medical device and biotech companies at various stages of development and is especially interested in product solutions for musculoskeletal disease.  MB Venture Partners currently manages two funds totaling $76 million under management.

Primus Capital Funds is a Cleveland, Ohio-based venture capital firm committed to funding private companies with exceptional growth potential. Primus invests in companies at all stages of development, with a particular emphasis on growth capital financing, and concentrates on three industries where it has significant investment experience: business services, media and communications, and healthcare. Primus began investing in 1983 and has established a national reputation for funding successful companies. Primus currently manages $625 million of private equity capital across five funds and has invested in over 100 companies since its inception.

Visit their website

Reservoir Venture Partners, a venture capital firm located in Columbus, Ohio, brings capital, business-building acumen, and a strong network to entrepreneurs and their teams. Reservoir targets investments in seed and early-stage technology-focused companies with an emphasis on biosciences and information technology. The firm focuses on investments in Ohio and throughout the Midwest.

Visit their website

Thomas, McNerney & Partners, LLC, is a health care private equity firm that invests in life science and medical technology companies, and has offices in Connecticut, Minneapolis and San Francisco. The firm's partners have successfully funded companies at all stages of their development, having collectively invested over $500 million in more than 40 entities. With a multi-stage investment approach, Thomas, McNerney & Partners provides seed and early stage funding to help entrepreneurs launch companies, as well as growth capital to emerging companies for furthering clinical development or for expansion of product commercialization. The firm is also involved in spinning-out products and divisions from major medical device and pharmaceutical companies to form new entities, consolidating companies through roll-up strategies and participating in recapitalizations. Thomas, McNerney & Partners is targeting investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as other areas utilizing medical technology innovation.

Visit their website